Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| BIONTECH | 9 | 13 | +0,87 % | ||
| TRAVERE THERAPEUTICS | 8 | 11 | -0,80 % | ||
| ILLUMINA | 7 | - | -0,68 % | ||
| VERICEL | 5 | - | 0,00 % | ||
| AMGEN | 4 | 27 | +0,18 % | ||
| BIOGEN | 3 | 54 | -2,02 % | ||
| ALNYLAM PHARMACEUTICALS | 3 | 9 | +0,54 % | ||
| GILEAD SCIENCES | 3 | 5 | +0,08 % | ||
| APELLIS PHARMACEUTICALS | 3 | 4 | +2,16 % | ||
| LEXEO THERAPEUTICS | 3 | 3 | -8,50 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09:14 | BIONTECH SE ADR - Stabilität in ruhiger Marktphase | 10 | Maximilian Berger | ||
| 08:18 | AstraZeneca stock rating reiterated at Buy by Guggenheim ahead of Q4 results | 4 | Investing.com | ||
| 08:10 | Guggenheim bestätigt Kaufempfehlung für AstraZeneca vor Quartalszahlen | 3 | Investing.com Deutsch | ||
| 08:06 | Madrigal Pharmaceuticals stock maintains Buy rating at Goldman Sachs | 3 | Investing.com | ||
| 07:45 | Milliardenmarkt Onkologie: Der nächste Blockbuster? Pharma-Riesen setzen auf Milliardenmarkt für Brustkrebs-Impfung | Hotstock Investor | |||
| 02:06 | cathie wood's ARK stock buys INTELLIA, continues trend | 11 | Investing.com | ||
| Di | JPM26: Biotech's M&A lift, the 'new' Biogen and Merck's $70B target | 8 | BioPharma Dive | ||
| Di | Eli Lilly Stock Rallies as Ventyx Deal Calms Wegovy Concerns | 39 | MarketBeat | ||
| Di | Faruqi & Faruqi LLP: INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Aquestive Therapeutics | 233 | Newsfile | Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses in Aquestive Therapeutics to Contact Him Directly to Discuss Their OptionsIf... ► Artikel lesen | |
| Di | Gentherapie-Entwickler Solid Biosciences meldet Fortschritte in klinischen Studien | 1 | Investing.com Deutsch | ||
| Di | Praxis Precision Medicines, Inc.: Praxis Precision Medicines Appoints Global Epilepsy Leader Dr. Orrin Devinsky as Head of Clinical Strategy | 3 | GlobeNewswire (USA) | ||
| Di | Solid Biosciences advances gene therapy trials for rare diseases | 1 | Investing.com | ||
| Di | Solid Biosciences Inc.: Solid Biosciences Provides 2026 Outlook Underscoring Neuromuscular and Cardiac Pipeline Momentum and Expanded Access to Next-Generation Capsid AAV-SLB101 | 2 | GlobeNewswire (USA) | ||
| Di | JPM26: Ionis, bolstered by strong launch of Tryngolza, doubles its sales projection in new indication to $2B | 5 | FiercePharma | ||
| Di | Foghorn Therapeutics, Inc.: Foghorn Therapeutics Announces Closing of $50 Million Registered Direct Financing at a 30% Premium | 1 | GlobeNewswire (USA) | ||
| Di | Crinetics Pharmaceuticals, Inc. - 8-K, Current Report | - | SEC Filings | ||
| Di | ACADIA PHARMACEUTICALS INC - 8-K, Current Report | - | SEC Filings | ||
| Di | BREAKING: Biontech im Kaufrausch - kommt jetzt der nächste Sprung? - jetzt lesen! | Hebelschein-Spekulant | |||
| Di | BioAge Labs extends rally after updating early-stage trial data for lead drug | 3 | Seeking Alpha | ||
| Di | Modella AI: AstraZeneca kauft KI-Firma zur Beschleunigung der Medikamentenentwicklung | 14 | manager-magazin.de |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .